Transaction #33971 · Form 4 · 0001213900-26-110808
Nano-X Imaging Ltd. · Purchase · Ordinary Shares
Nano-X Imaging Ltd. · Transacted October 19, 2026 · Filed October 20, 2026
What does this filing report?
An SEC Form 4 filing for Nano-X Imaging Ltd. records a purchase involving Ordinary Shares on October 19, 2026. The reported quantity was 25,000. The filing date is October 20, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Nano-X Imaging Ltd.
- Company CIK
- 0001795251
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 25,000
- Reported price
- 0.45
- Reference value
- 11,250
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 90,443
- Ownership description
- By a wholly owned company
- SEC acceptance time
- Oct 20, 2026, 6:01 AM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Meltzer Erez ↗
Chief Executive Officer · Director
CIK 0001371973
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
- F2
- There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3
- The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
- F4
- The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
- F5
- The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).
Remarks
See Exhibit 24.1: Power of Attorney
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.